257 related articles for article (PubMed ID: 15572279)
21. Selective mechanism-based inactivation of rat CYP2D by 4-allyloxymethamphetamine.
Lin LY; Fujimoto M; Distefano EW; Schmitz DA; Jayasinghe A; Cho AK
J Pharmacol Exp Ther; 1996 May; 277(2):595-603. PubMed ID: 8627536
[TBL] [Abstract][Full Text] [Related]
22. Polysaccharide peptides from COV-1 strain of Coriolus versicolor inhibit tolbutamide 4-hydroxylation in the rat in vitro and in vivo.
Yeung JH; Chan SL; Or PM
Food Chem Toxicol; 2006 Aug; 44(8):1414-23. PubMed ID: 16698161
[TBL] [Abstract][Full Text] [Related]
23. Direct and indirect interactions between antidepressant drugs and CYP2C6 in the rat liver during long-term treatment.
Daniel WA; Haduch A; Syrek M; Boksa J
Eur Neuropsychopharmacol; 2006 Dec; 16(8):580-7. PubMed ID: 16503401
[TBL] [Abstract][Full Text] [Related]
24. Developmental changes in the catalytic activity and expression of CYP2D isoforms in the rat liver.
Chow T; Imaoka S; Hiroi T; Funae Y
Drug Metab Dispos; 1999 Feb; 27(2):188-92. PubMed ID: 9929501
[TBL] [Abstract][Full Text] [Related]
25. Differential striatal levels of TNF-alpha, NFkappaB p65 subunit and dopamine with chronic typical and atypical neuroleptic treatment: role in orofacial dyskinesia.
Bishnoi M; Chopra K; Kulkarni SK
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1473-8. PubMed ID: 18554768
[TBL] [Abstract][Full Text] [Related]
26. The inhibitory effect of propranolol pretreatment on its own metabolism in the rat.
Schneck DW; Pritchard JF
J Pharmacol Exp Ther; 1981 Sep; 218(3):575-81. PubMed ID: 6267246
[TBL] [Abstract][Full Text] [Related]
27. Comparative neurochemical changes associated with chronic administration of typical and atypical neuroleptics: implications in tardive dyskinesia.
Bishnoi M; Kumar A; Chopra K; Kulkarni SK
Indian J Exp Biol; 2007 Feb; 45(2):175-9. PubMed ID: 17375557
[TBL] [Abstract][Full Text] [Related]
28. Influence of neuroleptics on cytotoxic activity of macrophages in rats.
Madej A; Belowski D; Kowalski J; Herman ZS
Boll Chim Farm; 1998 May; 137(5):135-9. PubMed ID: 9689898
[TBL] [Abstract][Full Text] [Related]
29. Different effects of amitriptyline and imipramine on the pharmacokinetics and metabolism of perazine in rats.
Daniel WA; Syrek M; Haduch A; Wójcikowski J
J Pharm Pharmacol; 2000 Dec; 52(12):1473-81. PubMed ID: 11197075
[TBL] [Abstract][Full Text] [Related]
30. The 1'-hydroxylation of Rac-bufuralol by rat brain microsomes.
Coleman T; Spellman EF; Rostami-Hodjegan A; Lennard MS; Tucker GT
Drug Metab Dispos; 2000 Sep; 28(9):1094-9. PubMed ID: 10950855
[TBL] [Abstract][Full Text] [Related]
31. Concurrent subacute exposure to arsenic through drinking water and malathion via diet in male rats: effects on hepatic drug-metabolizing enzymes.
Naraharisetti SB; Aggarwal M; Sarkar SN; Malik JK
Arch Toxicol; 2008 Aug; 82(8):543-51. PubMed ID: 18528686
[TBL] [Abstract][Full Text] [Related]
32. The Atypical Antipsychotic Lurasidone Affects Brain but Not Liver Cytochrome P450 2D (CYP2D) Activity. A Comparison with Other Novel Neuroleptics and Significance for Drug Treatment of Schizophrenia.
Danek PJ; Daniel WA
Cells; 2022 Nov; 11(21):. PubMed ID: 36359909
[TBL] [Abstract][Full Text] [Related]
33. [Changes in testosterone oxidation in rat liver microsomes after prolonged administration of ethylmorphine].
Pospelova LN; Chistiakov VV
Biokhimiia; 1981 Feb; 46(2):347-52. PubMed ID: 7248389
[TBL] [Abstract][Full Text] [Related]
34. Chronic treatment with asenapine affects cytochrome P450 2D (CYP2D) in rat brain and liver. Pharmacological aspects.
Danek PJ; Bromek E; Haduch A; Daniel WA
Neurochem Int; 2021 Dec; 151():105209. PubMed ID: 34666077
[TBL] [Abstract][Full Text] [Related]
35. Inhibitory effect of rifampicin on the depressive action of interleukin-1 on cytochrome P-450-linked monooxygenase system.
Kurokohchi K; Yoneyama H; Nishioka M; Ichikawa Y
Metabolism; 2001 Feb; 50(2):231-6. PubMed ID: 11229434
[TBL] [Abstract][Full Text] [Related]
36. Promazine pharmacokinetics during concurrent treatment with tricyclic antidepressants.
Syrek M; Wójcikowski J; Daniel WA
Pol J Pharmacol; 1997; 49(6):453-62. PubMed ID: 9566049
[TBL] [Abstract][Full Text] [Related]
37. The inhibitory effect of tannic acid on cytochrome P450 enzymes and NADPH-CYP reductase in rat and human liver microsomes.
Yao HT; Chang YW; Lan SJ; Yeh TK
Food Chem Toxicol; 2008 Feb; 46(2):645-53. PubMed ID: 17950511
[TBL] [Abstract][Full Text] [Related]
38. In vivo administration of H2 blockers, cimetidine and ranitidine, reduced the contents of the cytochrome P450IID (CYP2D) subfamily and their activities in rat liver microsomes.
Orishiki M; Matsuo Y; Nishioka M; Ichikawa Y
Int J Biochem; 1994 Jun; 26(6):751-8. PubMed ID: 8063004
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of cytochrome P450 enzymes by rhein in rat liver microsomes.
Tang JC; Yang H; Song XY; Song XH; Yan SL; Shao JQ; Zhang TL; Zhang JN
Phytother Res; 2009 Feb; 23(2):159-64. PubMed ID: 18814214
[TBL] [Abstract][Full Text] [Related]
40. Effect of mirtazapine on the CYP2D activity in the primary culture of rat hepatocytes.
Haduch A; Bromek E; Kot M; Jemnitz K; Veres Z; Vereczkey L; Daniel WA
Pharmacol Rep; 2006; 58(6):979-84. PubMed ID: 17220559
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
